Novel crystal of (S)-(+)-2-(2-chlorophenyl)-2-hydroxy-et hyl carbamate

Details for Australian Patent Application No. 2007307029 (hide)

Owner TransForm Pharmaceuticals, Inc.

Inventors Peterson, Matthew

Agent Shelston IP

Pub. Number AU-A-2007307029

PCT Pub. Number WO2008/045391

Priority 60/828,392 06.10.06 US

Filing date 5 October 2007

Wipo publication date 17 April 2008

International Classifications

A61K 31/27 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07C 271/10 (2006.01) Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/045391 Priority application(s): WO2008/045391

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007307031-Imidazoand triazolo-pyridine compounds and methods of use therof

2007307024-Flexible endoscopic stitching devices